Stocks Comparison
Johnson & Johnson vs Merck: revenue, profit, margins and growth compared
Johnson & Johnson brought in $94.2B of revenue in fiscal 2025, Merck $65B in fiscal 2025. Revenue changed by +6.0% at Johnson & Johnson and +1.3% at Merck on the year before, so Johnson & Johnson grew faster. Johnson & Johnson kept 28.5% of its revenue as net profit, Merck 28.1%. Free cash flow was $19.7B at Johnson & Johnson and $12.4B at Merck.
Side by side, latest fiscal year
| JNJ | MRK | |
|---|---|---|
| Fiscal year ended | FY2025 (December 28, 2025) | FY2025 (December 31, 2025) |
| Revenue | $94.2B | $65B |
| Revenue growth | +6.0% | +1.3% |
| Net income | $26.8B | $18.3B |
| Net margin | 28.5% | 28.1% |
| Free cash flow | $19.7B | $12.4B |
| Free cash flow margin | 20.9% | 19.0% |
| Earnings per share (diluted) | $11.03 | $7.28 |
| Cash | $19.7B | $14.6B |
| Debt | $41.4B | $49.1B |
| Price to earnings | 24.6 | 20.4 |
| Market value | $653.6B | $367.1B |
| Dividend yield | 1.90% | 2.20% |
| Rank by revenue in sector | #9 of 523 · Health care | #12 of 523 · Health care |
Over the years
Questions about Johnson & Johnson and Merck
Which is bigger by revenue, Johnson & Johnson or Merck?
Johnson & Johnson is bigger by revenue: $94.2B in fiscal 2025, against $65B for Merck in fiscal 2025.
Which keeps more of its revenue as profit, Johnson & Johnson or Merck?
Johnson & Johnson had a net margin of 28.5% in fiscal 2025; Merck had 28.1% in fiscal 2025.
Which grew revenue faster, Johnson & Johnson or Merck?
In their latest fiscal years revenue changed by +6.0% at Johnson & Johnson and +1.3% at Merck.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.